ATC Group: C05AD01 Lidocaine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C05AD01 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C05 Vasoprotectives
3 C05A Agents for treatment of hemorrhoids and anal fissures for topical use
4 C05AD Local anesthetics
5 C05AD01 Lidocaine

Active ingredients in C05AD01

Active Ingredient Description
Lidocaine

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

Hong Kong (HK)

Israel (IL)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

Poland (PL)

Romania (RO)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.